Sign In

Login

Password

Forgot Password ? Sign Up

Uwe-Frithjof Haustein (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Uwe-Frithjof Haustein" in German language version.

refsWebsite
Global rank German rank
35nih.gov
4th place
7th place
34doi.org
2nd place
3rd place
31zdb-katalog.de
123rd place
6th place
6saw-leipzig.de
low place
4,636th place
3uni-leipzig.de
2,676th place
817th place
2d-nb.info
511th place
112th place
1slaek.de
low place
low place
1uniklinikum-leipzig.de
low place
low place
1acatech.de
low place
5,844th place
1oup.com
485th place
715th place
1aerzteblatt.de
3,043rd place
200th place

acatech.de

aerzteblatt.de

d-nb.info

doi.org

  • Uwe-Frithjof Haustein: Tubular structures in affected and normal skin in chronic discoid and systemic lupus erythematosus: electron microscopic studies. In: British Journal of Dermatology. Band 89, Nr. 1, 1973, ISSN 1365-2133, S. 1–14, doi:10.1111/j.1365-2133.1973.tb01909.x.
  • J. Schaller, W. Feleke, U. F. Haustein, C. Baldauf, G. Kunze: HLA in bullous pemphigoid. The probable role of HLA-B7 as a marker for poor responders to immunosuppressive therapy. In: International Journal of Dermatology. Band 30, Nr. 1, Januar 1991, ISSN 0011-9059, S. 36–38, doi:10.1111/j.1365-4362.1991.tb05876.x, PMID 1993562.
  • U. F. Haustein, I. Lohrisch, K. Herrmann: Pathogenetic studies in bullous pemphigoid--review of the literature and our own results. In: The Journal of Dermatology. Band 11, Nr. 6, Dezember 1984, ISSN 0385-2407, S. 508–518, doi:10.1111/j.1346-8138.1984.tb01517.x, PMID 6399050.
  • U. F. Haustein: The role of bullous pemphigoid antibodies in dermal-epidermal separation. In: The Journal of Investigative Dermatology. Band 92, Nr. 1, Januar 1989, ISSN 0022-202X, S. 133, doi:10.1111/1523-1747.ep13071360, PMID 2642509.
  • K. Herrmann, U.-F. Haustein, H.-J. Böhme, I. Lohrisch: Acid lysosomal hydrolases in systemic sclerosis and other connective tissue diseases. In: British Journal of Dermatology. Band 106, Nr. 5, 1982, ISSN 1365-2133, S. 523–528, doi:10.1111/j.1365-2133.1982.tb04554.x.
  • K. Herrmann, M. Heckmann, M. Kulozik, U. F. Haustein, T. Krieg: Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. In: The Journal of Investigative Dermatology. Band 97, Nr. 2, August 1991, ISSN 0022-202X, S. 219–222, doi:10.1111/1523-1747.ep12480157, PMID 1649227.
  • K. Herrmann, E. Schulze, M. Heckmann, I. Schubert, M. Meurer: Type III collagen aminopropeptide and laminin P1 levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma. In: The British Journal of Dermatology. Band 123, Nr. 1, Juli 1990, ISSN 0007-0963, S. 1–7, doi:10.1111/j.1365-2133.1990.tb01818.x, PMID 2117968.
  • U. Anderegg, A. Saalbach, U. F. Haustein: Chemokine release from activated human dermal microvascular endothelial cells--implications for the pathophysiology of scleroderma? In: Archives of Dermatological Research. Band 292, Nr. 7, Juli 2000, ISSN 0340-3696, S. 341–347, doi:10.1007/s004030000134, PMID 10966058.
  • U.-F. Haustein: MikrochimerismusNeuer Denkansatz für die Pathogenese der systemischen Sklerodermie. In: Der Hautarzt. Band 51, Nr. 2, 1. Februar 2000, ISSN 0017-8470, S. 59–62, doi:10.1007/s001050050012.
  • Uwe-Frithjof Haustein: Systemic Sclerosis - An Update. In: Laboratory Medicine. Band 42, Nr. 9, 1. September 2011, ISSN 0007-5027, S. 562–572, doi:10.1309/LM9OB5BZ4OSNVGVF (oup.com [abgerufen am 10. August 2020]).
  • Philipp Rehberger, Petra Beckheinrich-Mrowka, Uwe-Frithjof Haustein, Michael Sticherling: Prostacyclin analogue iloprost influences endothelial cell-associated soluble adhesion molecules and growth factors in patients with systemic sclerosis: a time course study of serum concentrations. In: Acta Dermato-Venereologica. Band 89, Nr. 3, 2009, ISSN 0001-5555, S. 245–249, doi:10.2340/00015555-0632, PMID 19479119.
  • U. F. Haustein, V. Ziegler: Environmentally induced systemic sclerosis-like disorders. In: International Journal of Dermatology. Band 24, Nr. 3, April 1985, ISSN 0011-9059, S. 147–151, doi:10.1111/j.1365-4362.1985.tb05745.x, PMID 2581908.
  • M. H. Rustin, H. A. Bull, V. Ziegler, J. Mehlhorn, U. F. Haustein: Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. In: The British Journal of Dermatology. Band 123, Nr. 6, Dezember 1990, ISSN 0007-0963, S. 725–734, doi:10.1111/j.1365-2133.1990.tb04189.x, PMID 2176091.
  • A. Saalbach, U. Aneregg, M. Bruns, E. Schnabel, K. Herrmann: Novel fibroblast-specific monoclonal antibodies: properties and specificities. In: The Journal of Investigative Dermatology. Band 106, Nr. 6, Juni 1996, ISSN 0022-202X, S. 1314–1319, doi:10.1111/1523-1747.ep12349035, PMID 8752676.
  • A. Saalbach, R. Kraft, K. Herrmann, U. F. Haustein, U. Anderegg: The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. In: Archives of Dermatological Research. Band 290, Nr. 7, Juli 1998, ISSN 0340-3696, S. 360–366, doi:10.1007/s004030050318, PMID 9749990.
  • A. Saalbach, G. Aust, U. F. Haustein, K. Herrmann, U. Anderegg: The fibroblast-specific MAb AS02: a novel tool for detection and elimination of human fibroblasts. In: Cell and Tissue Research. Band 290, Nr. 3, Dezember 1997, ISSN 0302-766X, S. 593–599, doi:10.1007/s004410050964, PMID 9369534.
  • A. Saalbach, T. Wetzig, U. F. Haustein, U. Anderegg: Detection of human soluble Thy-1 in serum by ELISA. Fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. In: Cell and Tissue Research. Band 298, Nr. 2, November 1999, ISSN 0302-766X, S. 307–315, doi:10.1007/s004419900079, PMID 10571119.
  • A. Saalbach, U. F. Haustein, U. Anderegg: A ligand of human thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated thy-1-positive microvascular endothelial cells and fibroblasts. In: The Journal of Investigative Dermatology. Band 115, Nr. 5, November 2000, ISSN 0022-202X, S. 882–888, doi:10.1046/j.1523-1747.2000.00104.x, PMID 11069627.
  • Anne Wetzel, Tino Wetzig, Uwe F. Haustein, Michael Sticherling, Ulf Anderegg: Increased neutrophil adherence in psoriasis: role of the human endothelial cell receptor Thy-1 (CD90). In: The Journal of Investigative Dermatology. Band 126, Nr. 2, Februar 2006, ISSN 0022-202X, S. 441–452, doi:10.1038/sj.jid.5700072, PMID 16374458.
  • E. Wandel, A. Grasshoff, M. Mittag, U. F. Haustein, A. Saalbach: Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. In: Experimental Dermatology. Band 9, Nr. 1, Februar 2000, ISSN 0906-6705, S. 34–41, doi:10.1034/j.1600-0625.2000.009001034.x, PMID 10688373.
  • Anja Saalbach, Anne Wetzel, Uwe-Frithjof Haustein, Michael Sticherling, Jan C. Simon: Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium. In: Oncogene. Band 24, Nr. 29, 7. Juli 2005, ISSN 0950-9232, S. 4710–4720, doi:10.1038/sj.onc.1208559, PMID 15897908.
  • Ulf Anderegg, Kerstin Breitschwerdt, Martin J. Köhler, Michael Sticherling, Uwe-Frithjof Haustein: MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF-beta and pro-inflammatory cytokines. In: Experimental Dermatology. Band 14, Nr. 9, September 2005, ISSN 0906-6705, S. 709–718, doi:10.1111/j.0906-6705.2005.00349.x, PMID 16098131.
  • G. Petter, U.-F. Haustein: Pathohistologische und klinische Prognosefaktoren beim Plattenepithelkarzinom der Haut Ein Beitrag zur multizentrischen Karzinomstudie der Vereinigung für Operative und Onkologische Dermatologie. In: Hautarzt. Nr. 50, 1999, S. 412–417, doi:10.1007/s001050050933.
  • G. Petter, U.-F. Haustein: Seltene und neu beschriebene histologische Varianten des kutanen Plattenepithelkarzinoms Klassifikation nach Histopathologie, Zytomorphologie und Malignität. In: Hautarzt. Nr. 52, 2001, S. 288–297, doi:10.1007/s001050051310.
  • V. Shamanin, H. zur Hausen, D. Lavergne, Ch. M. Proby, I. M. Leigh, Ch. Neumann, H. Hamm, M. Goos, U.-F. Haustein, E. G. Jung, G. Plewig, H. Wolff, E.-M. de Villiers: Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. In: J. Nat. Cancer Inst. Nr. 88, 1996, S. 802–811, doi:10.1093/jnci/88.12.802.
  • U.-F. Haustein: Angiosarcoma of the face and scalp. In: Int. J. Dermatology. Nr. 30, 1991, S. 851–856, doi:10.1111/j.1365-4362.1991.tb04350.x.
  • U. Paasch, U. F. Haustein: [Treatment of endemic scabies with allethrin, permethrin and ivermectin. Evaluation of a treatment strategy]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 52, Nr. 1, Januar 2001, ISSN 0017-8470, S. 31–37, doi:10.1007/s001050051258, PMID 11220236.
  • U. Paasch, U. F. Haustein: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. In: International Journal of Dermatology. Band 39, Nr. 6, Juni 2000, ISSN 0011-9059, S. 463–470, doi:10.1046/j.1365-4362.2000.00990.x, PMID 10944095.
  • H.-J. Glander, K. Herrmann, U.-F. Haustein: [Impairment of the fertilization process by adherence of microorganism to the equatorial fibronectin band (EFB) of human sperm. A pathogenic hypothesis.] In: Int. Urol. & Nephrol. Nr. 22, 1990, S. 483–486, doi:10.1007/BF02549782, PMID 2076940.
  • J. Kleine-Tebbe, A. Heinatz, I. Gräser, H. Dautel, G. Nordskov-Hansen, S. Kespohl, H. P. Rihs, M. Raulf-Heimsoth, G. Vater, M. Rytter, U.-F. Haustein: [Risk of IgE-mediated allergic sensitizations and severe anaphylactic reactions due to bites of the european pigeon tick (Argas reflexus).] In: J. Allergy Clin. Immunol. Nr. 117, 2006, S. 190–195, doi:10.1016/j.jaci.2005.08.056, PMID 16387605.
  • J. Kleine-Tebbe, A. Wangorsch, L. Vogel, D.-N. Crowell, U.-F. Haustein, S. Vieths: [Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1-related PR-10 protein in soybean, SAM22]. In: J. Allergy Clin. Immunol. Nr. 110, 2002, S. 797–804, doi:10.1067/mai.2002.128946, PMID 12417891.
  • P. Nenoff, U.-F. Haustein, W. Brandt: [Antifungal activity of the essential oil of Malaleuca alternifolia (Tea Tree Oil) against pathogenic fungi in vitro.] In: Skin Pharmacol. Nr. 9, 1996, S. 388–394, doi:10.1159/000211450, PMID 9055360.
  • P. Nenoff, S. Kellermann, L.-C. Horn, S. Keiner, F. Bootz, S. Schneider, U.-F. Haustein: [Case Report. Mycotic arteritis due to Aspergillus fumigatus in a diabetic with retrobulbar aspergillosis and mycotic meningitis.] In: Mycoses. Nr. 44, 2001, S. 407–414, doi:10.1046/j.1439-0507.2001.00687.x, PMID 11766108.
  • P. Nenoff, P. Reinl, U.-F. Haustein: [Der Hefepilz Malassezia: Erreger, Pathogenese, Therapie. ]. In: Der Hautarzt. Nr. 52, 2001, S. 73–86, doi:10.1007/s001050051268, PMID 11220247.

nih.gov

ncbi.nlm.nih.gov

  • J. Schaller, W. Feleke, U. F. Haustein, C. Baldauf, G. Kunze: HLA in bullous pemphigoid. The probable role of HLA-B7 as a marker for poor responders to immunosuppressive therapy. In: International Journal of Dermatology. Band 30, Nr. 1, Januar 1991, ISSN 0011-9059, S. 36–38, doi:10.1111/j.1365-4362.1991.tb05876.x, PMID 1993562.
  • U. F. Haustein, I. Lohrisch, K. Herrmann: Pathogenetic studies in bullous pemphigoid--review of the literature and our own results. In: The Journal of Dermatology. Band 11, Nr. 6, Dezember 1984, ISSN 0385-2407, S. 508–518, doi:10.1111/j.1346-8138.1984.tb01517.x, PMID 6399050.
  • U. F. Haustein: The role of bullous pemphigoid antibodies in dermal-epidermal separation. In: The Journal of Investigative Dermatology. Band 92, Nr. 1, Januar 1989, ISSN 0022-202X, S. 133, doi:10.1111/1523-1747.ep13071360, PMID 2642509.
  • K. Herrmann, M. Heckmann, M. Kulozik, U. F. Haustein, T. Krieg: Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. In: The Journal of Investigative Dermatology. Band 97, Nr. 2, August 1991, ISSN 0022-202X, S. 219–222, doi:10.1111/1523-1747.ep12480157, PMID 1649227.
  • K. Herrmann, E. Schulze, M. Heckmann, I. Schubert, M. Meurer: Type III collagen aminopropeptide and laminin P1 levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma. In: The British Journal of Dermatology. Band 123, Nr. 1, Juli 1990, ISSN 0007-0963, S. 1–7, doi:10.1111/j.1365-2133.1990.tb01818.x, PMID 2117968.
  • U. Anderegg, A. Saalbach, U. F. Haustein: Chemokine release from activated human dermal microvascular endothelial cells--implications for the pathophysiology of scleroderma? In: Archives of Dermatological Research. Band 292, Nr. 7, Juli 2000, ISSN 0340-3696, S. 341–347, doi:10.1007/s004030000134, PMID 10966058.
  • U. F. Haustein, U. Anderegg: Pathophysiology of scleroderma: an update. In: Journal of the European Academy of Dermatology and Venereology: JEADV. Band 11, Nr. 1, Juli 1998, ISSN 0926-9959, S. 1–8, PMID 9731958.
  • Philipp Rehberger, Petra Beckheinrich-Mrowka, Uwe-Frithjof Haustein, Michael Sticherling: Prostacyclin analogue iloprost influences endothelial cell-associated soluble adhesion molecules and growth factors in patients with systemic sclerosis: a time course study of serum concentrations. In: Acta Dermato-Venereologica. Band 89, Nr. 3, 2009, ISSN 0001-5555, S. 245–249, doi:10.2340/00015555-0632, PMID 19479119.
  • U. F. Haustein, V. Ziegler: Environmentally induced systemic sclerosis-like disorders. In: International Journal of Dermatology. Band 24, Nr. 3, April 1985, ISSN 0011-9059, S. 147–151, doi:10.1111/j.1365-4362.1985.tb05745.x, PMID 2581908.
  • U. F. Haustein, V. Ziegler, K. Herrmann: [Chemically-induced scleroderma]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 43, Nr. 8, August 1992, ISSN 0017-8470, S. 469–474, PMID 1506211.
  • U. F. Haustein: [Exacerbation of progressive scleroderma following roentgen therapy]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 41, Nr. 8, August 1990, ISSN 0017-8470, S. 448–450, PMID 2177048.
  • J. Varga, U. F. Haustein, R. H. Creech, J. P. Dwyer, S. A. Jimenez: Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. In: JAMA. Band 265, Nr. 24, 26. Juni 1991, ISSN 0098-7484, S. 3292–3295, PMID 2046111.
  • U. F. Haustein, U. Anderegg: Silica induced scleroderma--clinical and experimental aspects. In: The Journal of Rheumatology. Band 25, Nr. 10, Oktober 1998, ISSN 0315-162X, S. 1917–1926, PMID 9779844.
  • M. H. Rustin, H. A. Bull, V. Ziegler, J. Mehlhorn, U. F. Haustein: Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. In: The British Journal of Dermatology. Band 123, Nr. 6, Dezember 1990, ISSN 0007-0963, S. 725–734, doi:10.1111/j.1365-2133.1990.tb04189.x, PMID 2176091.
  • A. Saalbach, U. Aneregg, M. Bruns, E. Schnabel, K. Herrmann: Novel fibroblast-specific monoclonal antibodies: properties and specificities. In: The Journal of Investigative Dermatology. Band 106, Nr. 6, Juni 1996, ISSN 0022-202X, S. 1314–1319, doi:10.1111/1523-1747.ep12349035, PMID 8752676.
  • A. Saalbach, R. Kraft, K. Herrmann, U. F. Haustein, U. Anderegg: The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. In: Archives of Dermatological Research. Band 290, Nr. 7, Juli 1998, ISSN 0340-3696, S. 360–366, doi:10.1007/s004030050318, PMID 9749990.
  • A. Saalbach, G. Aust, U. F. Haustein, K. Herrmann, U. Anderegg: The fibroblast-specific MAb AS02: a novel tool for detection and elimination of human fibroblasts. In: Cell and Tissue Research. Band 290, Nr. 3, Dezember 1997, ISSN 0302-766X, S. 593–599, doi:10.1007/s004410050964, PMID 9369534.
  • A. Saalbach, T. Wetzig, U. F. Haustein, U. Anderegg: Detection of human soluble Thy-1 in serum by ELISA. Fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. In: Cell and Tissue Research. Band 298, Nr. 2, November 1999, ISSN 0302-766X, S. 307–315, doi:10.1007/s004419900079, PMID 10571119.
  • A. Saalbach, U. F. Haustein, U. Anderegg: A ligand of human thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated thy-1-positive microvascular endothelial cells and fibroblasts. In: The Journal of Investigative Dermatology. Band 115, Nr. 5, November 2000, ISSN 0022-202X, S. 882–888, doi:10.1046/j.1523-1747.2000.00104.x, PMID 11069627.
  • Anne Wetzel, Tino Wetzig, Uwe F. Haustein, Michael Sticherling, Ulf Anderegg: Increased neutrophil adherence in psoriasis: role of the human endothelial cell receptor Thy-1 (CD90). In: The Journal of Investigative Dermatology. Band 126, Nr. 2, Februar 2006, ISSN 0022-202X, S. 441–452, doi:10.1038/sj.jid.5700072, PMID 16374458.
  • E. Wandel, A. Grasshoff, M. Mittag, U. F. Haustein, A. Saalbach: Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. In: Experimental Dermatology. Band 9, Nr. 1, Februar 2000, ISSN 0906-6705, S. 34–41, doi:10.1034/j.1600-0625.2000.009001034.x, PMID 10688373.
  • Anja Saalbach, Anne Wetzel, Uwe-Frithjof Haustein, Michael Sticherling, Jan C. Simon: Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium. In: Oncogene. Band 24, Nr. 29, 7. Juli 2005, ISSN 0950-9232, S. 4710–4720, doi:10.1038/sj.onc.1208559, PMID 15897908.
  • Ulf Anderegg, Kerstin Breitschwerdt, Martin J. Köhler, Michael Sticherling, Uwe-Frithjof Haustein: MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF-beta and pro-inflammatory cytokines. In: Experimental Dermatology. Band 14, Nr. 9, September 2005, ISSN 0906-6705, S. 709–718, doi:10.1111/j.0906-6705.2005.00349.x, PMID 16098131.
  • U. F. Haustein, B. Hlawa: Treatment of scabies with permethrin versus lindane and benzyl benzoate. In: Acta Dermato-Venereologica. Band 69, Nr. 4, 1989, ISSN 0001-5555, S. 348–351, PMID 2472724.
  • U. F. Haustein: [Pyrethrin and pyrethroid (permethrin) in the treatment of scabies and pediculosis]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 42, Nr. 1, Januar 1991, ISSN 0017-8470, S. 9–15, PMID 2010292.
  • U. Paasch, U. F. Haustein: [Treatment of endemic scabies with allethrin, permethrin and ivermectin. Evaluation of a treatment strategy]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 52, Nr. 1, Januar 2001, ISSN 0017-8470, S. 31–37, doi:10.1007/s001050051258, PMID 11220236.
  • U. Paasch, U. F. Haustein: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. In: International Journal of Dermatology. Band 39, Nr. 6, Juni 2000, ISSN 0011-9059, S. 463–470, doi:10.1046/j.1365-4362.2000.00990.x, PMID 10944095.
  • H.-J. Glander, U.-F. Haustein: [Zur Behandlung sub- bzw. infertiler Ehepaare mittels Kryosperma. 1. Mitteilung: Untersuchungen zur Optimierung der Tiefgefrierkonservierung humaner Spermienzellen.] In: Dt. Gesundh.-Wesen. Nr. 33, 1978, S. 1211–1215, PMID 668502.
  • H.-J. Glander, K. Piskazeck, G. Mälzer, U. Graf, U.-F. Haustein: [Zur Behandlung sub- bzw. infertiler Ehepaare mittels Kryosperma. 2. Mitteilung: Praktisches Vorgehen und Ergebnisse der Insemination von Kryospermien.] In: Dt. Gesundh.-Wesen. Nr. 33, 1978, S. 1256–1260, PMID 668504.
  • H.-J. Glander, K. Herrmann, U.-F. Haustein: [Impairment of the fertilization process by adherence of microorganism to the equatorial fibronectin band (EFB) of human sperm. A pathogenic hypothesis.] In: Int. Urol. & Nephrol. Nr. 22, 1990, S. 483–486, doi:10.1007/BF02549782, PMID 2076940.
  • J. Kleine-Tebbe, A. Heinatz, I. Gräser, H. Dautel, G. Nordskov-Hansen, S. Kespohl, H. P. Rihs, M. Raulf-Heimsoth, G. Vater, M. Rytter, U.-F. Haustein: [Risk of IgE-mediated allergic sensitizations and severe anaphylactic reactions due to bites of the european pigeon tick (Argas reflexus).] In: J. Allergy Clin. Immunol. Nr. 117, 2006, S. 190–195, doi:10.1016/j.jaci.2005.08.056, PMID 16387605.
  • J. Kleine-Tebbe, A. Wangorsch, L. Vogel, D.-N. Crowell, U.-F. Haustein, S. Vieths: [Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1-related PR-10 protein in soybean, SAM22]. In: J. Allergy Clin. Immunol. Nr. 110, 2002, S. 797–804, doi:10.1067/mai.2002.128946, PMID 12417891.
  • P. Nenoff, U.-F. Haustein, W. Brandt: [Antifungal activity of the essential oil of Malaleuca alternifolia (Tea Tree Oil) against pathogenic fungi in vitro.] In: Skin Pharmacol. Nr. 9, 1996, S. 388–394, doi:10.1159/000211450, PMID 9055360.
  • P. Nenoff, S. Kellermann, L.-C. Horn, S. Keiner, F. Bootz, S. Schneider, U.-F. Haustein: [Case Report. Mycotic arteritis due to Aspergillus fumigatus in a diabetic with retrobulbar aspergillosis and mycotic meningitis.] In: Mycoses. Nr. 44, 2001, S. 407–414, doi:10.1046/j.1439-0507.2001.00687.x, PMID 11766108.
  • P. Nenoff, P. Reinl, U.-F. Haustein: [Der Hefepilz Malassezia: Erreger, Pathogenese, Therapie. ]. In: Der Hautarzt. Nr. 52, 2001, S. 73–86, doi:10.1007/s001050051268, PMID 11220247.

oup.com

academic.oup.com

saw-leipzig.de

slaek.de

uni-leipzig.de

research.uni-leipzig.de

uniklinikum-leipzig.de

zdb-katalog.de

  • Uwe-Frithjof Haustein: Tubular structures in affected and normal skin in chronic discoid and systemic lupus erythematosus: electron microscopic studies. In: British Journal of Dermatology. Band 89, Nr. 1, 1973, ISSN 1365-2133, S. 1–14, doi:10.1111/j.1365-2133.1973.tb01909.x.
  • J. Schaller, W. Feleke, U. F. Haustein, C. Baldauf, G. Kunze: HLA in bullous pemphigoid. The probable role of HLA-B7 as a marker for poor responders to immunosuppressive therapy. In: International Journal of Dermatology. Band 30, Nr. 1, Januar 1991, ISSN 0011-9059, S. 36–38, doi:10.1111/j.1365-4362.1991.tb05876.x, PMID 1993562.
  • U. F. Haustein, I. Lohrisch, K. Herrmann: Pathogenetic studies in bullous pemphigoid--review of the literature and our own results. In: The Journal of Dermatology. Band 11, Nr. 6, Dezember 1984, ISSN 0385-2407, S. 508–518, doi:10.1111/j.1346-8138.1984.tb01517.x, PMID 6399050.
  • U. F. Haustein: The role of bullous pemphigoid antibodies in dermal-epidermal separation. In: The Journal of Investigative Dermatology. Band 92, Nr. 1, Januar 1989, ISSN 0022-202X, S. 133, doi:10.1111/1523-1747.ep13071360, PMID 2642509.
  • K. Herrmann, U.-F. Haustein, H.-J. Böhme, I. Lohrisch: Acid lysosomal hydrolases in systemic sclerosis and other connective tissue diseases. In: British Journal of Dermatology. Band 106, Nr. 5, 1982, ISSN 1365-2133, S. 523–528, doi:10.1111/j.1365-2133.1982.tb04554.x.
  • K. Herrmann, M. Heckmann, M. Kulozik, U. F. Haustein, T. Krieg: Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. In: The Journal of Investigative Dermatology. Band 97, Nr. 2, August 1991, ISSN 0022-202X, S. 219–222, doi:10.1111/1523-1747.ep12480157, PMID 1649227.
  • K. Herrmann, E. Schulze, M. Heckmann, I. Schubert, M. Meurer: Type III collagen aminopropeptide and laminin P1 levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma. In: The British Journal of Dermatology. Band 123, Nr. 1, Juli 1990, ISSN 0007-0963, S. 1–7, doi:10.1111/j.1365-2133.1990.tb01818.x, PMID 2117968.
  • U. Anderegg, A. Saalbach, U. F. Haustein: Chemokine release from activated human dermal microvascular endothelial cells--implications for the pathophysiology of scleroderma? In: Archives of Dermatological Research. Band 292, Nr. 7, Juli 2000, ISSN 0340-3696, S. 341–347, doi:10.1007/s004030000134, PMID 10966058.
  • U. F. Haustein, U. Anderegg: Pathophysiology of scleroderma: an update. In: Journal of the European Academy of Dermatology and Venereology: JEADV. Band 11, Nr. 1, Juli 1998, ISSN 0926-9959, S. 1–8, PMID 9731958.
  • U.-F. Haustein: MikrochimerismusNeuer Denkansatz für die Pathogenese der systemischen Sklerodermie. In: Der Hautarzt. Band 51, Nr. 2, 1. Februar 2000, ISSN 0017-8470, S. 59–62, doi:10.1007/s001050050012.
  • Uwe-Frithjof Haustein: Systemic Sclerosis - An Update. In: Laboratory Medicine. Band 42, Nr. 9, 1. September 2011, ISSN 0007-5027, S. 562–572, doi:10.1309/LM9OB5BZ4OSNVGVF (oup.com [abgerufen am 10. August 2020]).
  • Philipp Rehberger, Petra Beckheinrich-Mrowka, Uwe-Frithjof Haustein, Michael Sticherling: Prostacyclin analogue iloprost influences endothelial cell-associated soluble adhesion molecules and growth factors in patients with systemic sclerosis: a time course study of serum concentrations. In: Acta Dermato-Venereologica. Band 89, Nr. 3, 2009, ISSN 0001-5555, S. 245–249, doi:10.2340/00015555-0632, PMID 19479119.
  • U. F. Haustein, V. Ziegler: Environmentally induced systemic sclerosis-like disorders. In: International Journal of Dermatology. Band 24, Nr. 3, April 1985, ISSN 0011-9059, S. 147–151, doi:10.1111/j.1365-4362.1985.tb05745.x, PMID 2581908.
  • U. F. Haustein, V. Ziegler, K. Herrmann: [Chemically-induced scleroderma]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 43, Nr. 8, August 1992, ISSN 0017-8470, S. 469–474, PMID 1506211.
  • U. F. Haustein: [Exacerbation of progressive scleroderma following roentgen therapy]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 41, Nr. 8, August 1990, ISSN 0017-8470, S. 448–450, PMID 2177048.
  • J. Varga, U. F. Haustein, R. H. Creech, J. P. Dwyer, S. A. Jimenez: Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. In: JAMA. Band 265, Nr. 24, 26. Juni 1991, ISSN 0098-7484, S. 3292–3295, PMID 2046111.
  • U. F. Haustein, U. Anderegg: Silica induced scleroderma--clinical and experimental aspects. In: The Journal of Rheumatology. Band 25, Nr. 10, Oktober 1998, ISSN 0315-162X, S. 1917–1926, PMID 9779844.
  • M. H. Rustin, H. A. Bull, V. Ziegler, J. Mehlhorn, U. F. Haustein: Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. In: The British Journal of Dermatology. Band 123, Nr. 6, Dezember 1990, ISSN 0007-0963, S. 725–734, doi:10.1111/j.1365-2133.1990.tb04189.x, PMID 2176091.
  • A. Saalbach, U. Aneregg, M. Bruns, E. Schnabel, K. Herrmann: Novel fibroblast-specific monoclonal antibodies: properties and specificities. In: The Journal of Investigative Dermatology. Band 106, Nr. 6, Juni 1996, ISSN 0022-202X, S. 1314–1319, doi:10.1111/1523-1747.ep12349035, PMID 8752676.
  • A. Saalbach, R. Kraft, K. Herrmann, U. F. Haustein, U. Anderegg: The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. In: Archives of Dermatological Research. Band 290, Nr. 7, Juli 1998, ISSN 0340-3696, S. 360–366, doi:10.1007/s004030050318, PMID 9749990.
  • A. Saalbach, G. Aust, U. F. Haustein, K. Herrmann, U. Anderegg: The fibroblast-specific MAb AS02: a novel tool for detection and elimination of human fibroblasts. In: Cell and Tissue Research. Band 290, Nr. 3, Dezember 1997, ISSN 0302-766X, S. 593–599, doi:10.1007/s004410050964, PMID 9369534.
  • A. Saalbach, T. Wetzig, U. F. Haustein, U. Anderegg: Detection of human soluble Thy-1 in serum by ELISA. Fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. In: Cell and Tissue Research. Band 298, Nr. 2, November 1999, ISSN 0302-766X, S. 307–315, doi:10.1007/s004419900079, PMID 10571119.
  • A. Saalbach, U. F. Haustein, U. Anderegg: A ligand of human thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated thy-1-positive microvascular endothelial cells and fibroblasts. In: The Journal of Investigative Dermatology. Band 115, Nr. 5, November 2000, ISSN 0022-202X, S. 882–888, doi:10.1046/j.1523-1747.2000.00104.x, PMID 11069627.
  • Anne Wetzel, Tino Wetzig, Uwe F. Haustein, Michael Sticherling, Ulf Anderegg: Increased neutrophil adherence in psoriasis: role of the human endothelial cell receptor Thy-1 (CD90). In: The Journal of Investigative Dermatology. Band 126, Nr. 2, Februar 2006, ISSN 0022-202X, S. 441–452, doi:10.1038/sj.jid.5700072, PMID 16374458.
  • E. Wandel, A. Grasshoff, M. Mittag, U. F. Haustein, A. Saalbach: Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. In: Experimental Dermatology. Band 9, Nr. 1, Februar 2000, ISSN 0906-6705, S. 34–41, doi:10.1034/j.1600-0625.2000.009001034.x, PMID 10688373.
  • Anja Saalbach, Anne Wetzel, Uwe-Frithjof Haustein, Michael Sticherling, Jan C. Simon: Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium. In: Oncogene. Band 24, Nr. 29, 7. Juli 2005, ISSN 0950-9232, S. 4710–4720, doi:10.1038/sj.onc.1208559, PMID 15897908.
  • Ulf Anderegg, Kerstin Breitschwerdt, Martin J. Köhler, Michael Sticherling, Uwe-Frithjof Haustein: MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF-beta and pro-inflammatory cytokines. In: Experimental Dermatology. Band 14, Nr. 9, September 2005, ISSN 0906-6705, S. 709–718, doi:10.1111/j.0906-6705.2005.00349.x, PMID 16098131.
  • U. F. Haustein, B. Hlawa: Treatment of scabies with permethrin versus lindane and benzyl benzoate. In: Acta Dermato-Venereologica. Band 69, Nr. 4, 1989, ISSN 0001-5555, S. 348–351, PMID 2472724.
  • U. F. Haustein: [Pyrethrin and pyrethroid (permethrin) in the treatment of scabies and pediculosis]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 42, Nr. 1, Januar 1991, ISSN 0017-8470, S. 9–15, PMID 2010292.
  • U. Paasch, U. F. Haustein: [Treatment of endemic scabies with allethrin, permethrin and ivermectin. Evaluation of a treatment strategy]. In: Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete. Band 52, Nr. 1, Januar 2001, ISSN 0017-8470, S. 31–37, doi:10.1007/s001050051258, PMID 11220236.
  • U. Paasch, U. F. Haustein: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. In: International Journal of Dermatology. Band 39, Nr. 6, Juni 2000, ISSN 0011-9059, S. 463–470, doi:10.1046/j.1365-4362.2000.00990.x, PMID 10944095.